Working... Menu
Trial record 36 of 8397 for:    Ophthalmopathy

Creation of the Biobank Related to Eye Disease (BioBank)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01240343
Recruitment Status : Completed
First Posted : November 15, 2010
Last Update Posted : January 11, 2018
Vision Research Foundation
Information provided by (Responsible Party):
Kimberly Drenser, William Beaumont Hospitals

Brief Summary:
The purpose of this study is to develop a BioBank (a specialized lab) and collect blood, fluids and/or other tissue samples to study eye diseases.

Condition or disease
Eye Diseases

Detailed Description:

The purpose of the Biobank related to eye disease at Beaumont Hospital is to help connect specialties and Specialists with each other, outside traditional limits of hospital or laboratory departments. The specimens (blood, fluids, and/or tissue samples) that will be collected from men, women and children will assist the researchers in a variety of studies on human eye diseases.

Research utilizing these specimens will allow for an increased understanding of the etiology, disease process, and response to treatments for various eye diseases, and will provide opportunities to subsequently improve our management decisions. Furthermore, projects that cross over between subspecialties are sparse and that is a limiting factor for the development of research that takes a more comprehensive approach.

Layout table for study information
Study Type : Observational
Actual Enrollment : 669 participants
Observational Model: Other
Time Perspective: Prospective
Official Title: Creation of the Biobank Related to Eye Disease
Study Start Date : June 2009
Actual Primary Completion Date : December 4, 2017
Actual Study Completion Date : December 4, 2017

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Eye Diseases

Primary Outcome Measures :
  1. To build the platform for a novel application of translational research that links cutting edge molecular laboratory techniques to clinical outcome studies
    Biobanks can be used for numberous discovery applications such as: identification and structural characterization of human genes, expression analysis, or discovery proteomics. Biological specimens, when coupled with standardized treatment and outcome data, will be essential resources for the identification, characterization and validation of biomarkers that are predictive of disease and treatment.

Biospecimen Retention:   Samples With DNA
blood, urine other body fluids (i.e. vitreous)

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
All pediatric and adult patients (age 0-99)who are being seen in the eye Dr. office and or having eye surgery

Inclusion Criteria: All pediatric and adult patients age 0-99 years -

Exclusion Criteria: All patients who do not agree to consent for collection of blood, fluids, tissue.

Patients who are cognitively impaired and are not able to verbalize understanding of the risks/benefits.


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01240343

Layout table for location information
United States, Michigan
William Beaumont Hospital
Royal Oak, Michigan, United States, 48073
Sponsors and Collaborators
Kimberly Drenser
Vision Research Foundation
Layout table for investigator information
Principal Investigator: Kimberly Drenser, MD, PhD Associated Retinal Consultants, P.C.

Layout table for additonal information
Responsible Party: Kimberly Drenser, M.D, Ph.D., William Beaumont Hospitals Identifier: NCT01240343     History of Changes
Other Study ID Numbers: 2009-057
First Posted: November 15, 2010    Key Record Dates
Last Update Posted: January 11, 2018
Last Verified: January 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Plan Description: No plan to share at this time

Keywords provided by Kimberly Drenser, William Beaumont Hospitals:

Additional relevant MeSH terms:
Layout table for MeSH terms
Eye Diseases